O carcinossarcoma 256 de Walker tem despertado o interesse de muitos pesquisadores como modelo experimental para estudo da biologia tumoral. OBJETIVO: estabelecer um modelo de tumor renal que possa ser usado para estudar in vivo e in vitro, as alterações impostas pelas neoplasias. MÉTODOS: utilizados vinte ratos Wistar, machos, adultos, pesando entre 250-300 g, oriundos do Laboratório de Cirurgia Experimental da Universidade Federal do Ceará. Sob anestesia inalatória procedia-se uma pequena incisão supraumbilical, e com manobra delicada fazia-se a exposição do rim direito. Neste órgão eram inoculadas 3x10(5) células tumorais viáveis. Os animais então eram mantidos em gaiolas individuais com as mesmas condições ambientais e com água e dieta ad libitum. RESULTADOS: o Carcinossarcoma 256 de Walker, implantado no parênquima do rim direito de ratos Wistar apresentou índice de pega de 100%, e crescimento rápido, invadiu por contiguidade as estruturas vizinhas, porém sem apresentar metástases, no entanto, levando os animais a óbito no curso médio de 14 dias. CONCLUSÃO: o modelo de implante de tumor de Walker no parênquima do rim direito de ratos Wistar é eficiente, tem reprodutibilidade, apresentando um índice de pega de 100%, e permitindo seu uso em linhas de pesquisa.
Angiogenesis is a multistep and redundant process crucial in several physiological events and pathophysiological developments such as cancer. Since the early findings by Folkman et al. that tumor growth is dependent on new vascularization, it is now broadly accepted that solid tumors cannot grow beyond 1-2 mm without a vascular supply of oxygen and nutrients.1) Further, there is a substantial body of evidence indicating that attacking tumor neovascularization is a promising approach in the treatment of cancer.2)The acquisition of an angiogenic phenotype in endothelial cells requires that angiogenic factors be overexpressed and released by cancer cells and host cells. These factors include fibroblastic growth factors and vascular endothelial growth factors that bind to specific receptors on the endothelial cell surface stimulating their migration and proliferation.3,4) On the other hand, the migration and organization of endothelial cells in capillary structures depend on the activity of the pericellular fibrinolytic system and the overexpression of different cellular adhesion molecules.5) All these events in the angiogenic process afford potential targets for an antiangiogenic therapy.Many compounds derived from various natural sources have been found to have antiangiogenic effects using both in vitro and in vivo models. 6) These compounds include extracts and fractions from cartilage. 7) Cartilage is an avascular tissue, and for this reason was believed to contain compounds with antiangiogenic activity. This hypothesis was first tested in 1973 by Eisenstein et al., who reported that cartilage extracted with guanidine 1 M did not resist to becoming vascularized when placed on the chick chorioallantoic membrane (CAM).8) It was later demonstrated by Folkman and Ingber that cartilage could inhibit tumor-induced angiogenesis in the CAM model. 9) Based on those works, recent studies have shown that substances isolated from shark cartilage, for example U-995 and AE-941, inhibit angiogenesis and tumor growth in vivo. 10,11) Fontenele et al. recently described analgesic and antiinflammatory properties of a water soluble fraction (WSF) of shark cartilage that was attributed principally to a small peptide with a molecular weight of 2.3 KDa.12) In the latter work these in vivo pharmacological effects were observed with oral as well as intraperitoneally administration.The aims of the present study were a) to demonstrate the ability of oral shark cartilage to exert an inhibitory effect on rabbit cornea neovascularization induced by basic fibroblast growth factor (bFGF), and b) to examine in the same model a newly described bioactive fraction of shark cartilage for antiangiogenic activity. Several angiogenic inhibitors have been obtained from shark cartilage, some of these are currently in clinical trials for assessment of safety and therapeutic efficacy in humans. Still, shark cartilage taken orally is commonly used in alternative and complimentary medicine for various ailments including serious diseases such as cancer. Howe...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
334 Leonard St
Brooklyn, NY 11211
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.